Virtus ETF Advisers LLC Xencor Inc Transaction History

Virtus ETF Advisers LLC

  • $234 Million
  • Q4 2024

A detailed history of Virtus ETF Advisers LLC transactions in Xencor Inc stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 2,871 shares of XNCR stock, worth $31,121. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,871
Previous 4,323 33.59%
Holding current value
$31,121
Previous $86,000 24.42%
% of portfolio
0.03%
Previous 0.04%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$19.43 - $26.84 $28,212 - $38,971
-1,452 Reduced 33.59%
2,871 $65,000
Q3 2024

Nov 14, 2024
BUY
$15.7 - $21.65 $1,177 - $1,623
75 Added 1.77%
4,323 $86,000
Q2 2024

Aug 14, 2024
BUY
$18.21 - $24.5 $2,931 - $3,944
161 Added 3.94%
4,248 $80,000
Q1 2024

May 15, 2024
SELL
$18.65 - $26.52 $5,147 - $7,319
-276 Reduced 6.33%
4,087 $90,000
Q4 2023

Feb 15, 2024
BUY
$16.53 - $21.42 $10,595 - $13,730
641 Added 17.22%
4,363 $92,000
Q3 2023

Nov 07, 2023
SELL
$20.08 - $25.39 $7,529 - $9,521
-375 Reduced 9.15%
3,722 $74,000
Q2 2023

Aug 14, 2023
BUY
$24.77 - $29.9 $13,673 - $16,504
552 Added 15.57%
4,097 $102,000
Q1 2023

May 15, 2023
SELL
$25.95 - $36.95 $35,447 - $50,473
-1,366 Reduced 27.82%
3,545 $98,000
Q4 2022

Feb 14, 2023
SELL
$24.79 - $30.86 $7,660 - $9,535
-309 Reduced 5.92%
4,911 $127,000
Q3 2022

Nov 14, 2022
BUY
$24.62 - $32.44 $861 - $1,135
35 Added 0.68%
5,220 $136,000
Q2 2022

Aug 12, 2022
BUY
$19.74 - $29.01 $11,705 - $17,202
593 Added 12.91%
5,185 $142,000
Q1 2022

May 16, 2022
SELL
$26.68 - $41.63 $7,390 - $11,531
-277 Reduced 5.69%
4,592 $123,000
Q4 2021

Feb 14, 2022
SELL
$33.67 - $43.44 $27,676 - $35,707
-822 Reduced 14.44%
4,869 $195,000
Q3 2021

Nov 15, 2021
SELL
$30.65 - $35.68 $9,225 - $10,739
-301 Reduced 5.02%
5,691 $186,000
Q2 2021

Aug 10, 2021
SELL
$34.33 - $44.68 $18,915 - $24,618
-551 Reduced 8.42%
5,992 $207,000
Q1 2021

May 17, 2021
BUY
$40.81 - $53.88 $4,774 - $6,303
117 Added 1.82%
6,543 $282,000
Q4 2020

Feb 12, 2021
SELL
$36.63 - $47.63 $161,428 - $209,905
-4,407 Reduced 40.68%
6,426 $280,000
Q3 2020

Nov 13, 2020
SELL
$30.09 - $43.02 $44,894 - $64,185
-1,492 Reduced 12.11%
10,833 $420,000
Q2 2020

Aug 05, 2020
BUY
$27.76 - $33.42 $74,729 - $89,966
2,692 Added 27.95%
12,325 $399,000
Q1 2020

May 14, 2020
SELL
$20.69 - $37.79 $28,986 - $52,943
-1,401 Reduced 12.7%
9,633 $288,000
Q4 2019

Feb 13, 2020
BUY
$32.75 - $41.43 $97,234 - $123,005
2,969 Added 36.81%
11,034 $379,000
Q3 2019

Nov 12, 2019
SELL
$33.73 - $46.27 $15,144 - $20,775
-449 Reduced 5.27%
8,065 $272,000
Q2 2019

Aug 13, 2019
BUY
$29.6 - $40.93 $40,078 - $55,419
1,354 Added 18.91%
8,514 $348,000
Q1 2019

May 14, 2019
SELL
$27.85 - $38.09 $29,771 - $40,718
-1,069 Reduced 12.99%
7,160 $222,000
Q4 2018

Feb 05, 2019
SELL
$32.39 - $42.05 $106,239 - $137,924
-3,280 Reduced 28.5%
8,229 $298,000
Q3 2018

Nov 14, 2018
SELL
$35.69 - $47.65 $294,906 - $393,731
-8,263 Reduced 41.79%
11,509 $449,000
Q2 2018

Aug 10, 2018
SELL
$28.41 - $42.41 $448,366 - $669,314
-15,782 Reduced 44.39%
19,772 $732,000
Q1 2018

May 14, 2018
BUY
$21.18 - $33.78 $407,503 - $649,927
19,240 Added 117.94%
35,554 $1.07 Million
Q4 2017

Feb 14, 2018
BUY
$19.29 - $24.83 $8,352 - $10,751
433 Added 2.73%
16,314 $358,000
Q3 2017

Nov 14, 2017
BUY
$19.61 - $23.35 $28,473 - $33,904
1,452 Added 10.06%
15,881 $364,000
Q2 2017

Aug 14, 2017
BUY
N/A
14,429
14,429 $305,000

Others Institutions Holding XNCR

# of Institutions
200
Shares Held
73.7M
Call Options Held
1.7K
Put Options Held
4.2K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $647M
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email